top of page

Testimony before the FDA's Tobacco Product Scientific Advisory Committee Regarding Modified Risk Tobacco Product Orders for ZYN

  • Writer: Lindsey Stroud
    Lindsey Stroud
  • Jan 22
  • 1 min read

On January 22, 2026, Lindsey Stroud, President and Founder of Tobacco Harm Reduction 101, presented before the U.S. Food and Drug Administration's Tobacco Product Scientific Advisory Committee regarding modified risk tobacco product orders for ZYN oral nicotine pouches.


Read the full testimony below.


1 Comment


Guest
May 23

Managing a severe autoimmune condition often feels like fighting a losing battle against your own body. Heavy medications were just suppressing my symptoms while causing terrible side effects. Finding a clinical plasma cleansing protocol at https://ways2well.com/health/plasmapheresis changed my whole approach to healing. Extracting those aggressive autoantibodies directly provided massive relief for my swollen joints. Experiencing a calm immune system without relying on harsh drugs is life-changing.


Edited
Like

Help Spread the Truth About Tobacco Harm Reduction — Share This Now!

bottom of page